Speedier lab test could curb superbug threat in ICU pneumonia

This trial tests a faster method of identifying which antibiotics can kill the bacteria causing ventilator-associated pneumonia (VAP) in intensive care patients. The new approach, called direct antimicrobial susceptibility testing (DAST), gives results about a day earlier than standard testing. The goal is to see if this quicker information helps doctors choose effective antibiotics without relying on broad-spectrum drugs like carbapenems, potentially improving treatment and reducing antibiotic resistance.